Potential immunotherapy targets in recurrent cervical cancer

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Recurrent cervical cancer presents a significant clinical challenge.
• Understanding the tumor microenvironment is crucial for developing effective immunotherapies.

Purpose of the Study:

• To characterize the intra- and peritumoral immune cell profiles in recurrent cervical cancers.
• To identify potential immunotherapy targets based on immune cell distribution.

Main Methods:

• Analysis of 28 pelvic exenteration specimens using multiplex immunofluorescence.
• Antibodies targeted CD8, CD68, FoxP3, PD1, and PD-L1.
• Clinical data abstracted from electronic medical records.

Main Results:

• Higher densities of CD8+ cytotoxic T cells, CD68+ macrophages, and FoxP3+ regulatory T cells were observed in the peritumoral stroma compared to tumor tissue.
• Antigen-experienced T cells (PD1+) were more prevalent in peritumoral areas.
• Intratumoral macrophages correlated with regulatory T cells, suggesting an immunosuppressive role.

Conclusions:

• Cytotoxic T cells are less dense within tumors, indicating potential T cell exclusion or destruction.
• Intratumoral macrophages may contribute to an immunosuppressive tumor environment.
• Combination therapies targeting T cell trafficking and tumor-associated macrophages (TAMs) are proposed to improve anti-tumor immunity.